Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MC4R | P32245 | 5/20 | 0.52 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.50 |
| ▸ | CCKBR | P32239 | 5/20 | 0.49 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.49 |
| ▸ | CCKAR | P32238 | 1/20 | 0.49 |
| ▸ | CTSL | P07711 | 2/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.48 |
| ▸ | CTSK | P43235 | 2/20 | 0.48 |
| ▸ | CTSH | P09668 | 1/20 | 0.48 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29476484 | 0.95 | MC4R (0.50) | MC4RC5AR1CCKBRKISS1RCCKAR | |
| SCHEMBL29476447 | 0.95 | MC4R (0.50) | MC4RC5AR1CCKBRKISS1RCCKAR | |
| SCHEMBL29511062 | 0.94 | MC4R (0.51) | MC4RC5AR1KISS1RCTSLCTSS | |
| SCHEMBL30510360 | 0.92 | C5AR1 (0.58) | MC4RC5AR1 | |
| SCHEMBL29517075 | 0.92 | C5AR1 (0.54) | MC4RC5AR1 | |
| SCHEMBL10419744 | 0.92 | C5AR1 (0.51) | MC4RC5AR1KISS1RCTSLCTSS | |
| SCHEMBL29419493 | 0.89 | MC4R (0.52) | MC4RC5AR1KISS1R | |
| SCHEMBL31555133 | 0.89 | MC4R (0.52) | MC4RC5AR1KISS1R | |
| SCHEMBL5994667 | 0.89 | MC4R (0.56) | MC4RKISS1R | |
| SCHEMBL29419550 | 0.89 | MC4R (0.52) | MC4RC5AR1KISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116507353-A | Methods of treating melanocortin-4 receptor pathway-related disorders | 节奏制药公司 | 2023-07-28 | — | — | CN | disclosed |